Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990
Christopher M. McBride(Novartis (Switzerland)), Cynthia M. Shafer(Novartis (Switzerland)), Brandon Doughan, Kristin M. Brinner, Pietro Taverna, Zhenhai Gao(Jilin University), Daniel Poon(Rapt Therapeutics (United States)), Daniel L. Menezes(Bristol-Myers Squibb (Germany)), Kris Mendenhall, Nancy Pryer(Novartis (United States)), Timothy Machajewski(Allogene Therapeutics (United States)), Yongjin Xu, Dachuan Lei, Barry H. Levine(Novartis (Switzerland)), Alice Rico, Julie Qiaojin Lin(University of Hong Kong), William Antonios-McCrea(Novartis (Switzerland)), Yi Xia, Paul A. Barsanti, Susan Fong, Teresa E. Williams(Novartis (Switzerland)), Cornelia Bellamacina, Alicia K. Louie(Novartis (Switzerland)), Tinya J. Abrams, Yasheen Zhou, Thomas F. Hendrickson, Xiaodong Lin(Wenzhou City People's Hospital), Abran Costales(Novartis (Switzerland)), Michael Wang, Maureen McKenna(Novartis (Switzerland)), Paul A. Renhowe(Novartis (Switzerland))
Cited by 28
Related Papers
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
Attitudes and perceptions of UK medical students towards artificial intelligence and radiology: a multicentre survey
|Insights into Imaging|2020|492
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
|Nature Communications|2019|210
Food, Shelter and Safety Needs Motivating Homeless Persons' Visits to an Urban Emergency Department
|Annals of Emergency Medicine|2008|100